Skip to content

Clinical trials

Phase 3 Inflammation trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20071
20104
20171
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
AstraZeneca1
Eastman Dental Insitute and Hospital1
GlaxoSmithKline1
Lux Biosciences, Inc.1
Mundipharma Research Limited1
Novo Nordisk A/S1
Population Health Research Institute1
Pronova BioPharma1
aTyr Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation13
Arthritis4
Arthritis, Psoriatic4
Psoriasis4
Skin Diseases4
Pathologic Processes2
Asthma1
Atherosclerosis1
Bronchial Diseases1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.